We engineer high-conviction M&A transactions, capital raises, and strategic partnerships for enterprises demanding precision over promise.
Three focused practice areas delivering measurable outcomes — from origination through close. Fees tied to results, not retainers.
End-to-end mandate management from target identification to deal structuring, due diligence coordination, and post-merger integration planning.
Proprietary institutional relationships enable accelerated access to growth equity, mezzanine, and structured debt across domestic and global capital pools.
High-ticket B2B partnership origination, channel development, and revenue acceleration for enterprises targeting institutional buyers.
We operate where institutional credibility, sector depth, and relentless execution converge.
A structured five-phase methodology that eliminates ambiguity and maximises deal certainty at every inflection point.
Our mandates span five high-growth sectors where capital deployment and strategic consolidation are reshaping India's economic landscape.
India's manufacturing sector is undergoing rapid consolidation driven by PLI incentives, export-led growth, and global supply chain realignment. XRTM advises promoters and PE-backed manufacturers on growth capital, strategic acquisitions, and exit mandates across auto ancillaries, engineering goods, specialty chemicals, and FMCG.
India's IT and technology ecosystem continues to attract institutional capital at scale. XRTM works with SaaS founders, IT services firms, and product companies seeking growth equity, strategic acquirers, or structured exits — from Series A-equivalent mandates to mid-market M&A processes.
The renewable energy sector in India presents one of the largest capital deployment opportunities of the decade, backed by government policy, ESG mandates, and international climate finance. XRTM advises developers, IPPs, and technology providers on project finance, M&A, and institutional capital structuring for solar, wind, storage, and green hydrogen projects.
India is the pharmacy of the world, and its pharmaceutical and healthcare sector is ripe for consolidation, PE investment, and cross-border deal activity. XRTM advises promoter-owned pharma companies, CDMO operators, and healthcare chains on acquisitions, divestitures, and institutional capital raises across formulations, APIs, and specialty healthcare.
The Indian BFSI sector is experiencing rapid consolidation, regulatory evolution, and digital disruption. XRTM advises NBFCs, insurance intermediaries, wealth managers, and fintech platforms on capital raises, strategic partnerships, and M&A transactions that create durable competitive advantage in a rapidly evolving market.
From mid-market companies to large conglomerates — spanning Manufacturing, Information Technology, Green Energy, Pharma and Financial Services.
We engage exclusively with serious principals. Share the outline of your mandate and we will revert within one business day.
All submissions are treated as strictly confidential under NDA protocol.